Immediate Impact
3 from Science/Nature 60 standout
Citing Papers
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
Works of Mark Bartholomä being referenced
Identification, Characterization, and Suppression of Side Products Formed during the Synthesis of [177Lu]Lu-PSMA-617
2021
High-Resolution PET Imaging with Therapeutic Antibody-based PD-1/PD-L1 Checkpoint Tracers
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Mark Bartholomä | 1438 | 889 | 864 | 86 | 2.1k | |
| M.R.A. Pillai | 2020 | 926 | 601 | 102 | 2.8k | |
| Cathy S. Cutler | 1554 | 547 | 433 | 67 | 2.4k | |
| Kayhan Garmestani | 2364 | 744 | 802 | 66 | 3.1k | |
| Alan R. Fritzberg | 1803 | 769 | 626 | 84 | 2.6k | |
| Licia Uccelli | 1302 | 605 | 419 | 109 | 1.9k | |
| Adriano Duatti | 1846 | 691 | 716 | 131 | 2.5k | |
| B. Johannsen | 1409 | 343 | 679 | 140 | 2.3k | |
| Alan B. Packard | 1104 | 436 | 531 | 77 | 2.5k | |
| Hans‐Jürgen Pietzsch | 1659 | 556 | 806 | 122 | 2.5k | |
| Sudipta Chakraborty | 1775 | 702 | 629 | 173 | 2.6k |
All Works
Login with ORCID to disown or claim papers
Loading papers...